General Announcement::Board Meeting

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
20-May-2021 00:57:06
Status
New
Announcement Sub Title
Board Meeting
Announcement Reference
SG210520OTHRXO10
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary Compliance Officer
Effective Date and Time of the event
19/05/2021 00:00:00
Description (Please provide a detailed description of the event in the box below)
We have to inform you that, pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on Friday, May 28, 2021, inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2021 and to consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2021.

Attachments

SGX_BM_INTIMATION_28052021.pdf
Total size =45K